WO1999007240A1 - Glucosinolate-containing formulated foods - Google Patents
Glucosinolate-containing formulated foods Download PDFInfo
- Publication number
- WO1999007240A1 WO1999007240A1 PCT/GB1998/002370 GB9802370W WO9907240A1 WO 1999007240 A1 WO1999007240 A1 WO 1999007240A1 GB 9802370 W GB9802370 W GB 9802370W WO 9907240 A1 WO9907240 A1 WO 9907240A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seed
- mustard
- glucosinolate
- crucifer
- condiment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/18—Mustard
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
Definitions
- the present invention relates to food products, especially formulated foods (made to a recipe of ingredients) .
- the invention provides food products, especially condiment mustard, which provide to the consumer an elevated level of certain isothiocyanates, in particular those which have been found to have health benefits.
- Encouraging greater consumption of cruciferous vegetables or enhancing the levels of these specific glucosinolates in broccoli and other vegetables may provide a means to increase the dietary intake of these chemoprotectants . However, this may lead to the greater intake of other glucosinolates which also occur in vegetables which may have undesirable properties (Fenwick et al . , 1983).
- O97/09889 identifies cruciferous sources of cancer chemoprotective agents rich in glucosinolates. It suggests use of particularly young sprouts of crucifers as a dietary means of reducing the level of carcinogens in mammals.
- the use of crucifer seeds as a food or drink supplement is also mentioned in passing as a possibility, the emphasis of the document being on use of crucifer sprouts, with ground crucifer seed flour or meal suggested for incorporation into breads, other baked goods, or health drinks or shakes, and solvent extracts suggested for preparation of soups, teas or other drinks and infusions.
- the document states that seeds can be used in many different foods such as salads, granolas, breads and other baked goods, among others.
- the present invention has arisen in part from work showing that glucosinolates giving rise to isothiocyanates with desirable properties are found in high amounts in seeds of various particular crucifer species. It has been realised that these seeds may be used as sources of glucosinolates and isothiocyanates in the diet, especially in formulated foods to which whole or ground seed can simply be added. This is a much simpler approach than previously suggested ideas for breeding programmes to (try to) develop strains of vegetables such as broccoli with increased glucosinolate content.
- glucosinolates there exists in the diet a formulated food which is specifically "designed" to contain high levels of glucosinolates and whose very nature admits of ready addition of crucifer seed in order to provide increased levels of other, desirable glucosinolates.
- That food is condiment mustard, generally formulated using different combinations or proportions of water, mustard flour, usually wheat flour, and optionally sugar, salt and/or other additives to taste or as preservative .
- Mustard is one of the oldest recorded spices, with records dating back to about 3000 B.C.. In terms of quantity, it is probably the most important spice on the world market . In value terms it is exceeded only by pepper.
- the total annual world trade for use in condiment is estimated as 150 kilotonnes, the main manufacturing centres being USA, UK, France, Germany and Japan.
- Four species of mustard have been grown for use as a spice, but today only Sinapis alba (white mustard) and Brassica juncea (brown or Indian mustard) are grown on a large scale in Canada and Europe .
- Condiment mustards consist of two main types: "English mustard” , which includes p-hydroxybenzyl glucosinolate which is obtained from the seeds of Sinapis alba and contributes a "hot” flavour; and “French mustard”, which includes a blend of p-hydroxybenzyl glucosinolate with propenyl glucosinolate obtained from the seeds of Brassica juncea contributing a "pungent” flavour.
- Some mustards contain 2 -propenyl glucosinolate derived from the roots of Armoracia lopathifolia (horseradish) .
- the addition of other glucosinolates and isothiocyanates to mustard provides a convenient and pleasant means of enhancing the level of specific isothiocyanates in the diet.
- a formulated food including crucifer seed or a glucosinolate-containing extract thereof, said seed being other than mustard seed.
- a “formulated food” is a product made to a recipe of ingredients.
- a “formulated food” according to the present invention is an edible formulation or composition including crucifer seed or a glucosinolate-containing extract thereof (as disclosed) as well as at least one other ingredient, generally several ingredients. Consumer laws in many countries require ingredients in formulated foods to be indicated on sales packaging. Such food products may be processed on an industrial scale. Suitability for human consumption is preferred in the present invention.
- the glucosinolate is generally a dietary glucosinolate, i.e.
- Preferred glucosinolates are functional in the sense of being capable of inducing Phase 2 detoxification enzymes in murine hepatoma cells in culture. It is standard in the art to use murine hepatoma cells such as Hepa lclc7 cells in determination of quinone reductase (QR) activity induced by a test agent . QR activity may be determined by means of measurement of formation of blue-brown reduced tetrazolium dye, e.g. using an optical scanner and analysis of absorbance . (Prochanska and Santamaria (1988); Prochaska et al . (1992))
- the glucosinolate in the seed or extract is methylthioalkyl, methylsulphinylalkyl, methylsulphinylalkenyl or methylsulphonylalkyl homologues of propyl, butyl or pentyl glucosinolates .
- the glucosinolate in the seed or extract thereof is 3-methylsulphinylpropyl, 3-methylsulphonylpropyl , 4-methylsulphinylbutyl, 4-methylsulphinylbutenyl or 4- methylsulphonylbutyl glucosinolate.
- the isothiocyanates corresponding to these glucosinolates are particularly implicated in protection against cancer.
- glucosinolates and isothiocyanates which have desirable properties for inclusion or elevation in the diet may be provided in a formulated food according to the present invention using appropriate crucifer seed.
- Table 1 lists a number of wild and cultivated crucifers for which relative levels of various glucosinolates have been determined. Those identified as having a high level of a desirable glucosinolate are preferred for use in the invention (for instance, Cherianthus cheiri , B . oleracea var Italica or Raphanus sativus) . Daxenbichler et al . , 1991, have also reported the glucosinolate composition of seeds from various crucifers and those identified as having a high level of a desirable glucosinolate may be used advantageously in accordance with the present invention.
- Seed of B . rupestris, B . villosa or genotypes of Iberis spp. may be employed as sources of 3-methylsulphinylpropyl glucosinolates (shown to have Phase 2 enzyme induction activity) and genotypes of Alyssum may be used to provide methylsulphinylpentyl glucosinolate .
- Sources of 4-methylsulphinylbutenyl glucosinolate include the fodder radish cultivars Crail and Neris, and the salad radish cultivars French Breakfast and Snowball . These have greater than 75 ⁇ moles g "1 of 4-methylsulphinylbutenyl glucosinolate.
- Seed employed in the present invention may contain about any of the following amounts of glucosinolate of interest, in ascending order of preference ( ⁇ moles g "1 ) : 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90.
- Seed may be ground, for example to a coarse or fine powder, in any suitable mill or grinder, preferably at ambient temperature.
- the formulated food is a condiment mustard including seed of a crucifer other than mustard or a glucosinolate-containing extract of such seed.
- Mustard is a particularly appropriate foodstuff for addition of glucosinolate by means of other crucifer seed. For instance, it is not cooked so that high levels of isothiocyanates can be maintained, it naturally provides high levels of isothiocyanates, and its nature, flavour and consistency are such as to be compatible with addition of other crucifer seed and easy blending therewith.
- Modifying mustard in accordance with the present invention provides an easy and convenient way of increasing the consumption of these minor but important plant metabolites in the diet. It is thought that a high- fat, high-meat and low fibre diet encourages the production of carcinogens, and this may be partially responsible for the relatively high incidence of cancer in affluent western societies . As mustard is usually consumed with food products which have these characteristics (including "fast food"), it is possible that the consumption of a modified mustard product as provided by the present invention could have a significant impact on health.
- a condiment mustard formulation according to the invention may contain crucifer seed which w/w includes at least about 10%, preferably at least about 15%, more preferably at least about 20% more preferably at least about 25% and most preferably at least about 30% of crucifer seed other than mustard.
- the %w/w of non-mustard crucifer seed within the crucifer seed in the formulated food is preferably sufficient to induce Phase 2 detoxification enzymes, e.g. in murine hepatoma cells in culture (Zhang et al , 1994; Rawfiq et al , 1995).
- Experimental work using formulations containing crucifer seed including 30% w/w Crail radish seeds had demonstrated induction of Phase 2 enzymes in mouse hepatoma cells .
- Ciment seed other than mustard within a condiment mustard formulation in accordance with the present invention may be at least about 9%, or at least about 14%, or at least about 18%, or at least about 22%, or at least about 27% w/w of the condiment mustard formulation.
- Condiment mustard formulations may contain up to about 90% w/w seed.
- a further aspect of the present invention provides a method of increasing glucosinolate content of a formulated food particularly condiment mustard, including addition to or inclusion in the food of seed from a crucifer other than mustard, or a glucosinolate-containing extract thereof.
- Addition of glucosinolate to a formulated food may follow grinding of the crucifer seed.
- the method may be preceded by a step of providing a glucosinolate-containing crucifer seed extract .
- a glucosinolate-containing crucifer seed extract may be provided by means of hot, e.g. boiling water, providing an extract that is safe for human consumption. Seed may be placed into hot water for a short time of the order of a few minutes, e.g. about 3 minutes, and may then be centrifuged with supernatent being collected and used, or stored for later usage.
- Other solvents may be used in preparation of a seed extract, including liquid carbon dioxide, ethanol, methanol and others.
- the solvent is non-toxic for human consumption.
- the formulated food may be supplemented with this enzyme.
- ground up seed may serve this purpose - for instance mustard meal in the condiment formulation.
- Another aspect of the invention provides the use of crucifer seed other than mustard seed, or an extract of such seed, as a source of glucosinolate in a formulated food, thereby increasing the glucosinolate content of the food.
- the invention also provides use of such seed or extract for increasing, enhancing or supplementing the glucosinolated content of the food, preferably condiment mustard as discussed.
- a still further aspect of the present invention provides a method including identifying a crucifer species as having seed which contains a glucosinolate of interest, such as one implicated in protection against cancer as discussed herein, or selecting a crucifer species known to have seed which contains such a glucosinolate and formulating a composition for human consumption, particularly condiment mustard, including seed of the identified or selected crucifer species, or extract of such seed containing said glucosinolate.
- the seed may be ground as discussed.
- the composition may include one or more other ingredients, optionally including one or more ingredients of cruciferous origin such as mustard, cress or horseradish.
- the invention provides a method of increasing glucosinolate and/or isothiocyanate content in an individual (human or animal) , including administration (generally self-administration by ingestion) of a composition including seed of a crucifer other than mustard, or a glucosinolate-containing extract of such seed, particularly a condiment mustard formulation.
- a composition including seed of a crucifer other than mustard, or a glucosinolate-containing extract of such seed, particularly a condiment mustard formulation.
- Evidence provides indication that this has a protective effect against cancer.
- glucosinolates Preferred and advantageous glucosinolates, crucifers, formulated foods and compositions according to all aspects of the invention are as disclosed herein and discussed in relation to the first aspect.
- Figure 1 shows HPLC chromatograms of desulphoglucosinolates extracted from (Figure 1A) mustard powder, ( Figure IB) mustard powder with ground R . sativus seeds and (Figure 1C) mustard powder with ground C. cheiri seeds: 1: 3- methylsulphonylpropyl ; 2: 2 -propenyl; 3: 4- methylsulphinylbutenyl; 4: p-hydroxybenzyl; 5: 4-hydroxy-3- inolylmethyl; 6: benzyl (internal standard).
- Figure 2 shows induction data with error bars showing standard deviation for each data point (squares) and cytotoxicity (diamonds) .
- the glucosinolate content of the seed of a number of crucifers has been examined. Briefly, this was done by grinding seeds in a coffee grinder, extracting glucosinolates in hot methanol, converting to desulphoglucosinolates and analysing by HPLC, as described below.
- Selected crucifer seeds were then ground and mixed with mustard powder to give a modified mustard glucosinolate profile.
- Chieranthus cheiri cv Bedders Mixed was used as a source of 3- methylsulphonylpropyl .
- 400 ⁇ l of 16 mM benzyl glucosinolate was added to the samples as an internal standard (previous studies had confirmed that this glucosinolate does not occur in the crucifer seeds or commercial mustard powder) .
- the samples were incubated for 10 minutes at 70 °C and centrifuged at 2000 rpm for 2 minutes. The supernatant was then added to sephadex columns to which sulphatase had been added as described by Heaney et al (1983) .
- Unmodified mustard powder contained two major glucosinolates, 2-propenyl and p-hydroxybenzyl glucosinolate and minor amounts of 4-hydroxy-3-indolylmethyl glucosinolate. Addition of ground crucifer seed resulted in the presence of the desired glucosinolates, but with no other significant changes to the glucosinolate profile ( Figure 1; Table 2) . High levels of 3- methylsulphonylpropyl and 4-methylsulphinyl-3-butenyl glucosinolate were obtained from addition of C. cheiri and R . sativus seeds respectively, while the addition of B .
- oleracea seeds provided 4-methylsulphinylbutyl and smaller amounts of its precursor, 4-methylthiobutyl glucosinolate. Addition of R . sativus and B . oleracea seed also led to a small increase in the level of 4-hydroxy-3-indolylmethyl glucosinolate.
- Fresh broccoli is estimated to contain 34.5 ⁇ moles/100 g fresh wt of 4-methylsulphinylbutyl glucosinolate (unpublished data) .
- a 2 g portion of modified mustard could contain 85 ⁇ moles of glucosinolates which induce detoxification enzymes. This would be equivalent of eating 246 g of fresh, raw broccoli. As it is likely that cooking or blanching prior to freezing results in degradation of up to 50% of the glucosinolates
- glucosinolates have been proposed to have potential anticancer activity. This project was to determine: (1) if extracts from mustard and radish were able to induce the anticarcinogenic marker enzyme, quinone reductase, in Hepalclc7 cells; (2) the effect of storage on the activity in (1) .
- Ml 30% radish and mustard mixture
- M2 mustard alone
- M3 radish alone.
- Each mustard was sampled and ground in liquid nitrogen, and then freeze dried. From the dried material, approx. 150 mg of each dried material was milled in a waring blender and 10 ml hot 70% methanol added. 100 ⁇ l of 16 mM GT was added as an internal standard and samples incubated at 70 °C for 20 minutes with occasional mixing and then centrifuged at 3000 rpm for 5 min. The supernatants were applied to Sephadex columns to which Sepharose had been added as described by Heaney (1993) .
- the resulting concentrates were stored at -70 °C until tested in the quinone reductase (QR) assay. Testing in the QR assay was performed following the methods described by Prochaska and Santamaria (1988) . Each sample was tested over a range of concentrations up to 2.5 mg dry weight/ml.
- QR quinone reductase
- the mustard sample alone showed no significant activity in "fresh" samples. After storage the potential anticancer activity apparently increased. The mixture of radish and mustard was intermediate between the radish and mustard alone. This sample showed a slight decrease in activity with storage.
- Negri et al (1991) Vegetable and Fruit consumption and cancer risk. Int. J. Cancer 48: 350-354.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002299703A CA2299703A1 (en) | 1997-08-12 | 1998-08-06 | Glucosinolate-containing formulated foods |
AU86403/98A AU8640398A (en) | 1997-08-12 | 1998-08-06 | Glucosinolate-containing formulated foods |
EP98937685A EP1003386A1 (en) | 1997-08-12 | 1998-08-06 | Glucosinolate-containing formulated foods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9717104.5A GB9717104D0 (en) | 1997-08-12 | 1997-08-12 | Food products |
GB9717104.5 | 1997-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999007240A1 true WO1999007240A1 (en) | 1999-02-18 |
Family
ID=10817397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1998/002370 WO1999007240A1 (en) | 1997-08-12 | 1998-08-06 | Glucosinolate-containing formulated foods |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1003386A1 (en) |
AU (1) | AU8640398A (en) |
CA (1) | CA2299703A1 (en) |
GB (1) | GB9717104D0 (en) |
WO (1) | WO1999007240A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002045527A2 (en) * | 2000-12-08 | 2002-06-13 | Access Business Group International Llc. | Brassica vegetable composition and method for manufacture of same |
US6428822B1 (en) * | 2001-04-03 | 2002-08-06 | Chengzhi Life Science Company, Ltd. | Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification |
DE10308298A1 (en) * | 2003-02-26 | 2004-09-09 | Kullmer, Thomas, Priv. Doz. Dr. med. | Production of a plant preparation useful for treating cancer comprises extracting glucosinolates from plant material and enzymatically hydrolyzing the glucosinolates to isothiocyanates |
US7744937B2 (en) | 2005-08-09 | 2010-06-29 | Kraft Foods Global Brands Llc | Chemoprotectants from crucifer seeds and sprouts |
WO2010102936A1 (en) | 2009-03-12 | 2010-09-16 | Nestec S.A. | Electrostatic protein/glucosinolate complexes |
WO2012074412A1 (en) * | 2010-11-29 | 2012-06-07 | Comvita New Zealand Limited | Cancer chemoprotective product comprising glucoraphanin and/or glucoraphanen compound and myrosinase enzyme from brassicaceae plant sources |
US10925934B2 (en) | 2011-02-22 | 2021-02-23 | Caudill Seed and Warehouse Co., Inc. | Spray dried myrosinase and use to produce isothiocynates |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB601529A (en) * | 1943-01-19 | 1948-05-07 | Joseph Michael Van Eekeren | Mustard product and process of manufacturing the same |
WO1997009889A1 (en) * | 1995-09-15 | 1997-03-20 | Johns Hopkins School Of Medicine | Cancer chemoprotective food products |
-
1997
- 1997-08-12 GB GBGB9717104.5A patent/GB9717104D0/en active Pending
-
1998
- 1998-08-06 WO PCT/GB1998/002370 patent/WO1999007240A1/en not_active Application Discontinuation
- 1998-08-06 AU AU86403/98A patent/AU8640398A/en not_active Abandoned
- 1998-08-06 EP EP98937685A patent/EP1003386A1/en not_active Withdrawn
- 1998-08-06 CA CA002299703A patent/CA2299703A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB601529A (en) * | 1943-01-19 | 1948-05-07 | Joseph Michael Van Eekeren | Mustard product and process of manufacturing the same |
WO1997009889A1 (en) * | 1995-09-15 | 1997-03-20 | Johns Hopkins School Of Medicine | Cancer chemoprotective food products |
Non-Patent Citations (3)
Title |
---|
BARRETT J.E. ET AL.: "Protective effects of cruciferous seed meals and hulls against colon cancer in mice", CANCER LETTERS, vol. 127, no. 1-2, - 15 May 1998 (1998-05-15), pages 83 - 88, XP002086075 * |
FAHEY J.W. ET AL.: "Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens", PROC. NATL. ACAD. SCI., vol. 94, no. 19, - 1997, pages 10367 - 10372, XP002086077 * |
LEONI O., ET AL.: "Myrosinase-Generated Isothiocyanate from Glucosinolates: Isolates, Characterization and In Vitro Antiproliferative Studies", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 5, no. 9, - 1997, pages 1799 - 1806, XP002086076 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002045527A2 (en) * | 2000-12-08 | 2002-06-13 | Access Business Group International Llc. | Brassica vegetable composition and method for manufacture of same |
WO2002045527A3 (en) * | 2000-12-08 | 2002-10-10 | Alticor Inc | Brassica vegetable composition and method for manufacture of same |
US6428822B1 (en) * | 2001-04-03 | 2002-08-06 | Chengzhi Life Science Company, Ltd. | Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification |
DE10308298A1 (en) * | 2003-02-26 | 2004-09-09 | Kullmer, Thomas, Priv. Doz. Dr. med. | Production of a plant preparation useful for treating cancer comprises extracting glucosinolates from plant material and enzymatically hydrolyzing the glucosinolates to isothiocyanates |
US7744937B2 (en) | 2005-08-09 | 2010-06-29 | Kraft Foods Global Brands Llc | Chemoprotectants from crucifer seeds and sprouts |
WO2010102936A1 (en) | 2009-03-12 | 2010-09-16 | Nestec S.A. | Electrostatic protein/glucosinolate complexes |
EP2229823A1 (en) | 2009-03-12 | 2010-09-22 | Nestec S.A. | Electrostatic protein/glucosinolate complexes |
WO2012074412A1 (en) * | 2010-11-29 | 2012-06-07 | Comvita New Zealand Limited | Cancer chemoprotective product comprising glucoraphanin and/or glucoraphanen compound and myrosinase enzyme from brassicaceae plant sources |
US10925934B2 (en) | 2011-02-22 | 2021-02-23 | Caudill Seed and Warehouse Co., Inc. | Spray dried myrosinase and use to produce isothiocynates |
Also Published As
Publication number | Publication date |
---|---|
AU8640398A (en) | 1999-03-01 |
EP1003386A1 (en) | 2000-05-31 |
GB9717104D0 (en) | 1997-10-15 |
CA2299703A1 (en) | 1999-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mahloko et al. | Bioactive compounds, antioxidant activity and physical characteristics of wheat-prickly pear and banana biscuits | |
Sytar et al. | The contribution of buckwheat genetic resources to health and dietary diversity | |
Vardavas et al. | The antioxidant and phylloquinone content of wildly grown greens in Crete | |
Sobowale et al. | Nutritional potentials and chemical value of some tropical leafy vegetables consumed in south west Nigeria | |
Reda et al. | Nutritional composition, antinutritional factors, antioxidant activities, functional properties, and sensory evaluation of cactus pear (Opuntia ficus-indica) seeds grown in tigray region, Ethiopia | |
Kayode et al. | Physicochemical properties of processed aerial yam (Dioscorea bulbifera) and sensory properties of paste (amala) prepared with cassava flour | |
Fakhfakh et al. | The mallow, Malva aegyptiaca L.(Malvaceae): Phytochemistry analysis and effects on wheat dough performance and bread quality | |
González-Mendoza et al. | Phenolic compounds and physiochemical analysis of Physalis ixocarpa genotypes | |
Saeed et al. | Nutritional facts and free radical scavenging activity of turnip (Brassica rapa) from Pakistan | |
Song et al. | Effects of pumpkin (Cucurbita moschata duch.) leaf powder on quality characteristics, antioxidant activities, and retarding retrogradation by shelf-life of sponge cake | |
Cankurtaran et al. | Effect of partial replacement of wheat flour by taro and Jerusalem artichoke flours on chemical and sensory properties of tarhana soup | |
Amagloh et al. | Bioactive compounds and antioxidant activities in peeled and unpeeled sweetpotato roots of different varieties and clones in Uganda | |
Rabie et al. | Effect of Moringa oleifera leaves and seeds powder supplementation on quality characteristics of cookies | |
WO1999007240A1 (en) | Glucosinolate-containing formulated foods | |
Ponka et al. | Protein, mineral and amino acid content of some Cameroonian traditional dishes prepared from pumpkin (Cucurbita maxima Duch.) | |
Razzeto et al. | Evaluation and comparative study of the nutritional profile and antioxidant potential of new quinoa varieties | |
Aziz et al. | Exploring the effect of apricot addition on nutritional, antioxidant, textural and sensory characteristics of cookies apricot supplemented functional cookies | |
Habte et al. | Metaphysical analysis of the nutritional and therapeutic value of baobab (Adansonia Digitata L.) | |
Luta et al. | Bioactive compounds and antioxidant properties of some wild plants with potential culinary uses | |
Kim et al. | Antioxidant and antiproliferative activities of methanol extracts from leafy vegetables consumed in Korea | |
Ali et al. | Production of healthy chips ready to eat using potato, green pea and lupine flour for malnourished children | |
Adeyemi et al. | Chemical composition and antioxidant capacity of the leaf extract of Justicia insularis | |
Lim et al. | Chenopodium quinoa | |
ZEM et al. | Nutritional analysis of noodles with and without the additional of Pereskia aculeata | |
Rahmah et al. | Increasing levels of fibre and mineral (Fe, Ca, and K) in chicken meatballs added dragon fruit peel and oyster mushroom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2299703 Country of ref document: CA Ref country code: CA Ref document number: 2299703 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09485520 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998937685 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998937685 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998937685 Country of ref document: EP |